BackLexeo Therapeutics Overview

Lexeo Therapeutics Long Term Debt

Lexeo Therapeutics's long-term debt is $4.7M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$4.67M
↓ 30.84% YoYΔ $-2.08M vs prior year quarter

Peer average / median

Loading

Lexeo Therapeutics Long Term Debt History

Loading

Lexeo Therapeutics vs. peers: Long Term Debt Comparison

Loading

Lexeo Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lexeo Therapeutics (LXEO) FAQ

Lexeo Therapeutics (LXEO) currently reports a long-term debt of $4.7M as of March 2026. That compares with $6.8M in the prior-year period — down 30.8% year over year. Use the charts on this page to explore Lexeo Therapeutics's long-term debt history and peer comparisons.

Lexeo Therapeutics's long-term debt decreased from $6.8M to $4.7M — a 30.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lexeo Therapeutics reported $4.7M in long-term debt as of March 2026. That compares with $6.8M in the prior-year period — down 30.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $4.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lexeo Therapeutics, and consider following LXEO for alerts when major investors trade the stock.